These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19333613)

  • 1. Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation.
    Zepiridis L; Zafrakas M; Theodoridis TD; Assimakopoulos E; Tzevelekis P; Athanatos D; Bontis JN; Tarlatzis BC
    Arch Gynecol Obstet; 2009 Dec; 280(6):1041-4. PubMed ID: 19333613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of placenta increta: case report and literature review.
    Yarandi F; Eftekhar Z; Shojaei H; Rahimi-Sharbaf F; Baradaran F
    Acta Med Iran; 2011; 49(6):396-8. PubMed ID: 21874645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment and application of color Doppler in conservative management of abnormally adherent placenta.
    Merz W; Van de Vondel P; Strunk H; Geipel A; Gembruch U
    Ultraschall Med; 2009 Dec; 30(6):571-6. PubMed ID: 18773385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum monitoring of retained placenta.Two cases of abnormally adherent placenta.
    Torrenga B; Huirne JA; Bolte AC; van Waesberghe JH; de Vries JI
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):472-5. PubMed ID: 22731843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray scale and color Doppler sonography in the third stage of labor for early detection of failed placental separation.
    Krapp M; Baschat AA; Hankeln M; Gembruch U
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):138-42. PubMed ID: 10775997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial placenta increta and methotrexate therapy: three case reports.
    Pinho S; Sarzedas S; Pedroso S; Santos A; Rebordão M; Avillez T; Casal E; Hermida M
    Clin Exp Obstet Gynecol; 2008; 35(3):221-4. PubMed ID: 18754299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative treatment of placenta increta with methotrexate.
    Crespo R; Lapresta M; Madani B
    Int J Gynaecol Obstet; 2005 Nov; 91(2):162-3. PubMed ID: 16126207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
    Chen YT; Xu LF; Sun HL; Li HQ; Hu RM; Tan QY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):273-7. PubMed ID: 20646539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D volume contrast imaging (VCI) for the visualization of placenta previa increta and uterine wall thickness in a dichorionic twin pregnancy.
    Henrich W; Stupin JH
    Ultraschall Med; 2011 Aug; 32(4):406-11. PubMed ID: 21080310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent retained placenta percreta: methotrexate treatment and Doppler flow characteristics.
    Nijman RG; Mantingh A; Aarnoudse JG
    BJOG; 2002 May; 109(5):587-8. PubMed ID: 12066955
    [No Abstract]   [Full Text] [Related]  

  • 11. Log-linear human chorionic gonadotropin elimination in cases of retained placenta percreta.
    Stitely ML; Gerard Jackson M; Holls WH
    Arch Gynecol Obstet; 2014 Feb; 289(2):259-62. PubMed ID: 23843154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta increta: Use of dynamic MRI for diagnosis and evaluation of placental vascularity.
    Honnma H; Endo T; Hayashi T; Saito T
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):131-3. PubMed ID: 16962230
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ultrasonography of placenta previa at the third trimester of pregnancy: research for signs of placenta accreta/percreta and vasa previa. Prospective color and pulsed Doppler ultrasonography study of 45 cases].
    Mégier P; Gorin V; Desroches A
    J Gynecol Obstet Biol Reprod (Paris); 1999 Jun; 28(3):239-44. PubMed ID: 10456306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Placenta Percreta through a combinatorial treatment involving a Bakri Balloon and Methotrexate--a case report.
    Akdemir N; Cevrioğlu AS; Özden S; Gündüz Y; Ilhan G
    Ginekol Pol; 2015 Aug; 86(8):631-4. PubMed ID: 26492714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta.
    El Behery MM; Rasha L E; El Alfy Y
    Int J Gynaecol Obstet; 2010 Apr; 109(1):30-3. PubMed ID: 20070963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of prenatal diagnosis of placenta previa with placenta increta by transabdominal color Doppler ultrasound].
    Zhang L; Li P; He GL; Liu XH; Yang TZ; Luo H; Tian Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):799-802. PubMed ID: 17327106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous sulprostone infusion in the treatment of retained placenta.
    Stefanovic V; Paavonen J; Loukovaara M; Halmesmäki E; Ahonen J; Tikkanen M
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):426-32. PubMed ID: 22862433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate Treatment for Retained Placental Tissue after Second Trimester Termination of Pregnancy.
    Kreinin A; Saphier O; Silberstein T
    Isr Med Assoc J; 2018 Jun; 20(6):388-390. PubMed ID: 29911763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case report: seventeen year old primipara with placenta increta, treated with methotrexate].
    Arnadottir BT; Hardardóttir H; Marvinsdóttir B
    Laeknabladid; 2008 Jul; 94(7-8):549-52. PubMed ID: 18591730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placenta percreta: methotrexate treatment and MRI findings.
    Heiskanen N; Kröger J; Kainulainen S; Heinonen S
    Am J Perinatol; 2008 Feb; 25(2):91-2. PubMed ID: 18176907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.